ArticleCancer science2020
Budget impact analysis of treatment-free remission in nilotinib-treated Japanese chronic myeloid leukemia patients.
Kiyotaka Yamazaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it